Page last updated: 2024-11-04

sulfamethoxazole and Centriacinar Emphysema

sulfamethoxazole has been researched along with Centriacinar Emphysema in 3 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brändli, O1
Hasenhüttl, G1
Piolino, M1
de Kalbermatten, JP1
Dobjanski, S1
Granato, D1
Schelling, JL1

Trials

1 trial available for sulfamethoxazole and Centriacinar Emphysema

ArticleYear
[Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
    Schweizerische medizinische Wochenschrift, 1968, Nov-02, Volume: 98, Issue:44

    Topics: Aged; Bronchitis; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Drug Resis

1968

Other Studies

2 other studies available for sulfamethoxazole and Centriacinar Emphysema

ArticleYear
[Status asthmaticus following administration of drugs].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1988, Oct-18, Volume: 77, Issue:42

    Topics: Aged; Anti-Infective Agents; Asthma; Drug Combinations; Humans; Lung Diseases, Obstructive; Male; Mi

1988
[Management of bronchial infections].
    Wiener medizinische Wochenschrift (1946), 1973, Nov-03, Volume: 123, Issue:44

    Topics: Asthma; Bronchial Diseases; Bronchiectasis; Bronchitis; Bronchopneumonia; Chronic Disease; Drug Comb

1973